Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker AXSM
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Mark Jacobson Officer | AXSM Axsome Therapeutics, Inc. | 10,000 | $2.1M | 10b5-1 | Sep 3, 2026 | Form 4 ↗ same day · 10,000 shares | Form 144 ↗ |
| Aug 6, 2026 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 4,660 | $979.2K | 10b5-1 | Aug 6, 2026 | Form 4 ↗ 1 day later · 49,664 shares | Form 144 ↗ |
| Aug 5, 2026 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 45,004 | $9.6M | 10b5-1 | Aug 5, 2026 | Form 4 ↗ 2 days later · 49,664 shares | Form 144 ↗ |
| Jul 1, 2026 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 49,666 | $12.0M | 10b5-1 | Jul 1, 2026 | Form 4 ↗ same day · 49,666 shares | Form 144 ↗ |
| Jun 11, 2026 | Roger Jeffs Director | AXSM Axsome Therapeutics, Inc. | 286 | $71.2K | 10b5-1 | Jun 11, 2026 | Form 4 ↗ same day · 572 shares | Form 144 ↗ |
| Jun 10, 2026 | Susan Mahony Director | AXSM Axsome Therapeutics, Inc. | 300 | $73.9K | 10b5-1 | Jun 10, 2026 | Form 4 ↗ same day · 600 shares | Form 144 ↗ |
| Jun 10, 2026 | Roger Jeffs Director | AXSM Axsome Therapeutics, Inc. | 286 | $70.4K | 10b5-1 | Jun 10, 2026 | Form 4 ↗ 1 day later · 572 shares | Form 144 ↗ |
| Jun 10, 2026 | Mark Coleman Director | AXSM Axsome Therapeutics, Inc. | 643 | $160.1K | 10b5-1 | Jun 10, 2026 | Form 4 ↗ same day · 643 shares | Form 144 ↗ |
| Jun 9, 2026 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 49,670 | $12.2M | 10b5-1 | Jun 9, 2026 | Form 4 ↗ same day · 49,670 shares | Form 144 ↗ |
| Jun 9, 2026 | Nick Pizzie Officer | AXSM Axsome Therapeutics, Inc. | 33,000 | $7.9M | 10b5-1 | Jun 9, 2026 | Form 4 ↗ same day · 33,000 shares | Form 144 ↗ |
| Jun 9, 2026 | Susan Mahony Director | AXSM Axsome Therapeutics, Inc. | 300 | $71.2K | 10b5-1 | Jun 9, 2026 | Form 4 ↗ 1 day later · 600 shares | Form 144 ↗ |
| Jun 2, 2026 | Mark Coleman Director | AXSM Axsome Therapeutics, Inc. | 5,537 | $1.2M | 10b5-1 | Jun 2, 2026 | Form 4 ↗ same day · 11,537 shares | Form 144 ↗ |
| Jun 1, 2026 | Mark Coleman Director | AXSM Axsome Therapeutics, Inc. | 6,000 | $1.4M | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 1 day later · 17,537 shares | Form 144 ↗ |
| May 29, 2026 | Mark Coleman Director | AXSM Axsome Therapeutics, Inc. | 6,000 | $1.4M | 10b5-1 | May 29, 2026 | Form 4 ↗ 4 days later · 17,537 shares | Form 144 ↗ |
| May 5, 2026 | Mark Jacobson Officer | AXSM Axsome Therapeutics, Inc. | 233 | $52.0K | 10b5-1 | May 5, 2026 | Form 4 ↗ same day · 4,750 shares | Form 144 ↗ |
| May 5, 2026 amended | Mark Jacobson Officer | AXSM Axsome Therapeutics, Inc. | 4,517 | $1.0M | 10b5-1 | May 4, 2026 | Form 4 ↗ same day · 4,750 shares | Form 144/A ↗ |
| May 4, 2026 | Mark Jacobson Officer | AXSM Axsome Therapeutics, Inc. | 4,517 | $1.0M | — | May 4, 2026 | Form 4 ↗ 1 day later · 4,750 shares | Form 144 ↗ |
| Apr 22, 2026 | Maizel Ari Officer | AXSM Axsome Therapeutics, Inc. | 7,500 | $1.4M | 10b5-1 | Apr 22, 2026 | Form 4 ↗ 1 day later · 7,500 shares | Form 144 ↗ |
| Feb 26, 2026 | Mark Jacobson Officer | AXSM Axsome Therapeutics, Inc. | 35,378 | $5.8M | 10b5-1 | Feb 26, 2026 | Form 4 ↗ 1 day later · 35,378 shares | Form 144 ↗ |
| Feb 26, 2026 | Mark Coleman Director | AXSM Axsome Therapeutics, Inc. | 25,000 | $4.0M | 10b5-1 | Feb 26, 2026 | Form 4 ↗ 1 day later · 25,000 shares | Form 144 ↗ |
| Feb 2, 2026 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 32,410 | $6.0M | 10b5-1 | Feb 2, 2026 | Form 4 ↗ same day · 32,410 shares | Form 144 ↗ |
| Jan 22, 2026 | Nick Pizzie Officer | AXSM Axsome Therapeutics, Inc. | 12,000 | $2.3M | 10b5-1 | Jan 22, 2026 | Form 4 ↗ 1 day later · 12,000 shares | Form 144 ↗ |
| Jan 21, 2026 | Maizel Ari Officer | AXSM Axsome Therapeutics, Inc. | 7,500 | $1.4M | 10b5-1 | Jan 21, 2026 | Form 4 ↗ 2 days later · 7,500 shares | Form 144 ↗ |
| Jan 7, 2026 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 31,261 | $5.3M | 10b5-1 | Jan 7, 2026 | Form 4 ↗ same day · 139,414 shares | Form 144 ↗ |
| Jan 6, 2026 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 29,450 | $5.1M | 10b5-1 | Jan 6, 2026 | Form 4 ↗ 1 day later · 139,414 shares | Form 144 ↗ |
| Jan 5, 2026 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 78,703 | $13.5M | — | Jan 5, 2026 | Form 4 ↗ 2 days later · 139,414 shares | Form 144 ↗ |
| Dec 31, 2025 | Mark E. Saad Director | AXSM Axsome Therapeutics, Inc. | 37,577 | $6.2M | 10b5-1 | Dec 31, 2025 | Form 4 ↗ 2 days later · 37,577 shares | Form 144 ↗ |
| Dec 4, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 10,558 | $1.6M | 10b5-1 | Dec 4, 2025 | Form 4 ↗ same day · 79,973 shares | Form 144 ↗ |
| Dec 3, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 20,163 | $3.0M | 10b5-1 | Dec 3, 2025 | Form 4 ↗ 1 day later · 79,973 shares | Form 144 ↗ |
| Dec 2, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 49,252 | $7.0M | 10b5-1 | Dec 2, 2025 | Form 4 ↗ 2 days later · 79,973 shares | Form 144 ↗ |
| Nov 5, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 21,775 | $3.0M | 10b5-1 | Nov 5, 2025 | Form 4 ↗ same day · 163,939 shares | Form 144 ↗ |
| Nov 4, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 50,459 | $6.8M | 10b5-1 | Nov 4, 2025 | Form 4 ↗ 1 day later · 163,939 shares | Form 144 ↗ |
| Nov 3, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 91,705 | $12.4M | 10b5-1 | Nov 3, 2025 | Form 4 ↗ 2 days later · 163,939 shares | Form 144 ↗ |
| Oct 8, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 12,774 | $1.5M | 10b5-1 | Oct 8, 2025 | Form 4 ↗ same day · 45,384 shares | Form 144 ↗ |
| Oct 7, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 13,390 | $1.6M | 10b5-1 | Oct 7, 2025 | Form 4 ↗ 1 day later · 45,384 shares | Form 144 ↗ |
| Oct 6, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 19,220 | $2.3M | 10b5-1 | Oct 6, 2025 | Form 4 ↗ 2 days later · 45,384 shares | Form 144 ↗ |
| Sep 22, 2025 | Mark L. Jacobson Officer | AXSM Axsome Therapeutics, Inc. | 10,000 | $1.2M | 10b5-1 | Sep 22, 2025 | Form 4 ↗ same day · 10,000 shares | Form 144 ↗ |
| Sep 16, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 19,719 | $2.2M | 10b5-1 | Sep 16, 2025 | Form 4 ↗ same day · 34,973 shares | Form 144 ↗ |
| Sep 16, 2025 | Mark L. Jacobson Officer | AXSM Axsome Therapeutics, Inc. | 45,783 | $5.2M | 10b5-1 | Sep 16, 2025 | Form 4 ↗ 1 day later · 45,783 shares | Form 144 ↗ |
| Sep 15, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 15,254 | $1.8M | 10b5-1 | Sep 15, 2025 | Form 4 ↗ 1 day later · 62,880 shares | Form 144 ↗ |
| Sep 12, 2025 | Herriot Tabuteau Officer | AXSM Axsome Therapeutics, Inc. | 27,907 | $3.3M | 10b5-1 | Sep 12, 2025 | Form 4 ↗ 4 days later · 62,880 shares | Form 144 ↗ |
| Sep 5, 2025 | Mark E. Saad Director | AXSM Axsome Therapeutics, Inc. | 9,127 | $1.1M | 10b5-1 | Sep 5, 2025 | Form 4 ↗ same day · 9,127 shares | Form 144 ↗ |
| Sep 2, 2025 | Roger Jeffs Director | AXSM Axsome Therapeutics, Inc. | 13,464 | $1.7M | 10b5-1 | Sep 2, 2025 | Form 4 ↗ same day · 13,464 shares | Form 144 ↗ |
| Aug 29, 2025 | Roger Jeffs Director | AXSM Axsome Therapeutics, Inc. | 20,000 | $2.4M | 10b5-1 | Aug 29, 2025 | Form 4 ↗ same day · 60,000 shares | Form 144 ↗ |
| Aug 28, 2025 | Roger Jeffs Director | AXSM Axsome Therapeutics, Inc. | 20,000 | $2.4M | 10b5-1 | Aug 28, 2025 | Form 4 ↗ 1 day later · 60,000 shares | Form 144 ↗ |
| Aug 27, 2025 | Roger Jeffs Director | AXSM Axsome Therapeutics, Inc. | 20,000 | $2.4M | 10b5-1 | Aug 27, 2025 | Form 4 ↗ 2 days later · 60,000 shares | Form 144 ↗ |
| Aug 26, 2025 | Roger Jeffs Director | AXSM Axsome Therapeutics, Inc. | 20,000 | $2.4M | 10b5-1 | Aug 26, 2025 | Form 4 ↗ same day · 20,000 shares | Form 144 ↗ |
| Aug 22, 2025 | Roger Jeffs Director | AXSM Axsome Therapeutics, Inc. | 16,694 | $2.0M | 10b5-1 | Aug 22, 2025 | Form 4 ↗ 4 days later · 36,694 shares | Form 144 ↗ |
| Jun 23, 2025 | Hunter R. Murdock Officer | AXSM Axsome Therapeutics, Inc. | 6,014 | $602.1K | 10b5-1 | Jun 23, 2025 | Form 4 ↗ same day · 13,514 shares | Form 144 ↗ |
| Jun 20, 2025 | Hunter R. Murdock Officer | AXSM Axsome Therapeutics, Inc. | 7,500 | $768.5K | 10b5-1 | Jun 20, 2025 | Form 4 ↗ 3 days later · 13,514 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:24 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances